New Approaches to Psychiatric Diagnostic Classification

Recent findings in psychiatric genetics have crystallized concerns that diagnostic categories used in the clinic map poorly onto the underlying biology. If we are to harness developments in genetics and neuroscience to understand disease mechanisms and develop new treatments, we need new approaches to patient stratification that recognize the complexity and continuous nature of psychiatric traits and that are not constrained by current categorical approaches. Recognizing this, the National Institute for Mental Health (NIMH) has developed a novel framework to encourage more research of this kind. The implications of these recent findings and funding policy developments for neuroscience research are considerable.

[1]  M. Owen,et al.  Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity , 2015, Biological Psychiatry.

[2]  Stephan Heckers,et al.  Is schizoaffective disorder a useful diagnosis? , 2009, Current psychiatry reports.

[3]  Bruce N Cuthbert,et al.  The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology , 2014, World psychiatry : official journal of the World Psychiatric Association.

[4]  M. Maj Keeping an open attitude towards the RDoC project , 2014, World psychiatry : official journal of the World Psychiatric Association.

[5]  P. Donnelly,et al.  Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype , 2008, Molecular Psychiatry.

[6]  A. Abbott Novartis to shut brain research facility , 2011, Nature.

[7]  Carlos S. Moreno,et al.  Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes , 2011, PLoS genetics.

[8]  N. Craddock,et al.  The beginning of the end for the Kraepelinian dichotomy , 2005, British Journal of Psychiatry.

[9]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[10]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[11]  Kathryn Roeder,et al.  Most genetic risk for autism resides with common variation , 2014, Nature Genetics.

[12]  N. Craddock,et al.  Neurodevelopmental hypothesis of schizophrenia , 2011, The British journal of psychiatry : the journal of mental science.

[13]  J. Os,et al.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder , 2008, Psychological Medicine.

[14]  Peter Holmans,et al.  De novo CNVs in bipolar affective disorder and schizophrenia , 2014, Human molecular genetics.

[15]  G. Kirov,et al.  Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. , 2010, Archives of general psychiatry.

[16]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[17]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[18]  J. Sebat,et al.  CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics , 2012, Cell.

[19]  S. Hyman,et al.  The diagnosis of mental disorders: the problem of reification. , 2010, Annual review of clinical psychology.

[20]  M. Owen,et al.  The Research Domain Criteria: moving the goalposts to change the game , 2014, British Journal of Psychiatry.

[21]  D. Linden The Challenges and Promise of Neuroimaging in Psychiatry , 2012, Neuron.

[22]  T. Insel,et al.  Wesleyan University From the SelectedWorks of Charles A . Sanislow , Ph . D . 2010 Research Domain Criteria ( RDoC ) : Toward a New Classification Framework for Research on Mental Disorders , 2018 .

[23]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[24]  D. Geschwind,et al.  Autism genetics: searching for specificity and convergence , 2012, Genome Biology.

[25]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[26]  S. Djurovic,et al.  Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia , 2013, Molecular Psychiatry.

[27]  S. Grant Synaptopathies: diseases of the synaptome , 2012, Current Opinion in Neurobiology.

[28]  G. Baird,et al.  Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  Michael J. Owen,et al.  The Kraepelinian dichotomy – going, going... but still not gone , 2010, British Journal of Psychiatry.

[30]  T. Insel,et al.  Toward the future of psychiatric diagnosis: the seven pillars of RDoC , 2013, BMC Medicine.

[31]  Atta Abbas,et al.  DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION , 2013 .

[32]  S. Hyman,et al.  Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology , 2013, Neuron.

[33]  R. Kendell,et al.  Distinguishing between the validity and utility of psychiatric diagnoses. , 2003, The American journal of psychiatry.

[34]  A. Lilienfeld,et al.  Pregnancy experience and the development of behavior disorders in children. , 1956, The American journal of psychiatry.

[35]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[36]  J. Cooper Psychiatric diagnosis in New York and London;: A comparative study of mental hospital admissions, , 1972 .

[37]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[38]  W. Gaebel,et al.  Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. , 2007, Schizophrenia bulletin.

[39]  O. Ousley,et al.  Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. , 2006, Journal of child and adolescent psychopharmacology.